Turn Therapeutics Inc. Common Stock (TTRX) — Cash Flow-to-Debt Ratio
Turn Therapeutics Inc. Common Stock (TTRX) has a Cash Flow-to-Debt Ratio of -0.13x as of March 2026, meaning its operating cash flow of $-1.63 Million could theoretically repay 0% of its total liabilities ($12.53 Million) in one year. See Turn Therapeutics Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Turn Therapeutics Inc. Common Stock Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Turn Therapeutics Inc. Common Stock across 3 annual periods. Also explore Turn Therapeutics Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Turn Therapeutics Inc. Common Stock (2023–2025)
Year-by-year debt coverage analysis for Turn Therapeutics Inc. Common Stock. For market capitalisation and broader financial context, see Turn Therapeutics Inc. Common Stock (TTRX) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-2.56 Million | $7.48 Million | ▲ +43.9% |
| 2024 | -0.61x | $-1.36 Million | $2.23 Million | ▲ +14.4% |
| 2023 | -0.71x | $-1.38 Million | $1.93 Million | — |